Angela Cenci Nilsson

Title: Angela Cenci Nilsson: Innovator in Parkinson's Disease Treatment

Introduction

Angela Cenci Nilsson is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of neurotherapeutics, particularly in the treatment of Parkinson's Disease. Her innovative approach focuses on utilizing low doses of pridopidine to alleviate symptoms associated with parkinsonism.

Latest Patents

Angela holds a patent for her invention titled "Low dose pridopidine for Parkinson's Disease and other diseases associated with parkinsonism." This patent outlines a method for treating Parkinsonism or its symptoms through the administration of low doses of pridopidine. This breakthrough has the potential to improve the quality of life for many individuals affected by this debilitating condition. She has 1 patent to her name.

Career Highlights

Angela is currently affiliated with Prilenia Neurotherapeutics Ltd., where she continues her research and development efforts. Her work is characterized by a commitment to advancing therapeutic options for patients suffering from neurodegenerative diseases.

Collaborations

Throughout her career, Angela has collaborated with notable professionals in the field, including Michael Hayden and Michal Geva. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.

Conclusion

Angela Cenci Nilsson is a trailblazer in the field of neurotherapeutics, with her innovative work on pridopidine showcasing her dedication to improving treatment options for Parkinson's Disease. Her contributions are paving the way for future advancements in this critical area of medicine.